134 related articles for article (PubMed ID: 36331221)
1. Dorsal myelopathy after nelarabine and intrathecal methotrexate therapy.
Sawamura F; Natsume J; Nakata T; Muramatsu H; Takahashi Y
Pediatr Int; 2022 Jan; 64(1):e15334. PubMed ID: 36331221
[No Abstract] [Full Text] [Related]
2. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
Gosavi T; Diong CP; Lim SH
J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
[TBL] [Abstract][Full Text] [Related]
3. Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
Gollard RP; Selco S
J Clin Oncol; 2013 Jul; 31(19):e327-31. PubMed ID: 23715575
[No Abstract] [Full Text] [Related]
4. MR imaging in nelarabine-induced myelopathy.
Dua SG; Jhaveri MD
J Clin Neurosci; 2016 Jul; 29():205-6. PubMed ID: 26899359
[TBL] [Abstract][Full Text] [Related]
5. Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.
Lalayanni C; Baldoumi E; Papayiannopoulos S; Tziola K; Saloum R; Anagnostopoulos A
Curr Probl Cancer; 2017; 41(2):138-143. PubMed ID: 28169005
[TBL] [Abstract][Full Text] [Related]
6. Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report.
Amer-Salas N; González-Morcillo G; Rodríguez-Camacho JM; Cladera-Serra A
J Oncol Pharm Pract; 2021 Jan; 27(1):244-249. PubMed ID: 32517638
[TBL] [Abstract][Full Text] [Related]
7. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
[TBL] [Abstract][Full Text] [Related]
8. Myelopathy due to intrathecal chemotherapy: report of six cases.
Bay A; Oner AF; Etlik O; Yilmaz C; Caksen H
J Pediatr Hematol Oncol; 2005 May; 27(5):270-2. PubMed ID: 15891563
[TBL] [Abstract][Full Text] [Related]
9. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
10. [Necrotizing myelopathy after intrathecal methotrexate].
Sanhes L; Delmer A; Zittoun R
Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
[No Abstract] [Full Text] [Related]
11. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
[TBL] [Abstract][Full Text] [Related]
12. Pediatric T-ALL complicated by irreversible nelarabine neurotoxicity.
Kanayama T; Imamura T; Nakagawa N; Osone S; Hosoi H
Pediatr Int; 2017 Jul; 59(7):843-845. PubMed ID: 28745456
[No Abstract] [Full Text] [Related]
13. Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature.
Bidikian AH; Bazarbachi A; Hourani R; El-Cheikh J; Abou Dalle I
Curr Res Transl Med; 2021 Jul; 69(3):103296. PubMed ID: 34139603
[TBL] [Abstract][Full Text] [Related]
14. Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes.
McLean DR; Clink HM; Ernst P; Coates R; al Kawi MZ; Bohlega S; Omer S
Cancer; 1994 Jun; 73(12):3037-40. PubMed ID: 8200001
[TBL] [Abstract][Full Text] [Related]
15. Ascending myelopathy after intrathecal methotrexate.
Chiu YH; Yang E; Chen YC
Kaohsiung J Med Sci; 2021 Nov; 37(11):1018-1019. PubMed ID: 34292665
[No Abstract] [Full Text] [Related]
16. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T; Tanaka T; Hashimoto T; Isahaya K; Kubo Y; Yamano Y; Satomi K; Hiraoka N; Shirakawa N; Arakawa A; Ogawa C; Nishimura N; Aoki J; Ito A; Inamoto Y; Kim SW; Fukuda T
Int J Hematol; 2023 Jun; 117(6):933-940. PubMed ID: 36705847
[TBL] [Abstract][Full Text] [Related]
17. Severe, reversible nelarabine-induced neuropathy and myelopathy.
Alberti P; Parma M; Pioltelli P; Pogliani EM; Terruzzi E; Stasia A; Doni E; Cecchetti C; Cavaletti G
J Peripher Nerv Syst; 2016 Sep; 21(3):154-6. PubMed ID: 27117493
[No Abstract] [Full Text] [Related]
18. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
Wang Z; Xu W; Liu L; Ding Z
Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
[No Abstract] [Full Text] [Related]
19. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
[TBL] [Abstract][Full Text] [Related]
20. Dorsal column myelopathy following intrathecal chemotherapy for acute lymphoblastic leukemia.
Joseph PJ; Reyes MR
J Spinal Cord Med; 2014 Jan; 37(1):107-13. PubMed ID: 24090227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
